Introduction Excess body mass index (BMI) is associated with a higher risk of death in many
disease states, yet less is known about the impact of higher BMIs on clinical outcomes of …

Context: An accurate and sensitive high-performance liquid chromatography-ultraviolet
(HPLC-UV) assay method was developed for the determination of two penicillins in oral …

As the prevalence of obesity increases worldwide, clinicians will be more and more
frequently confronted with obese, critically ill patients. Optimal administration of antibiotics is …

The aim of this article is to demonstrate extreme interindividual variability of
piperacilin/tazobactam (PIP/TAZO) pharmacokinetics in critically ill morbidly obese patients …

As the prevalence of obesity continues to rise significantly worldwide, an increasing number
of overweight patients are expected to present to hospital with various pathological …

探讨肥胖特殊人群抗菌药物的合理使用. 本文对临床常用的抗菌药物在肥胖人群中临床应用进行
汇总, 对肥胖的分类, 常见的体重指标公式换算, 抗菌药物的药动学等均有所涉及 …

В настоящее время в развитых странах ожирением страдают от 15 до 50% населения.
Пациенты с ожирением имеют более высокий риск возникновения инфекций, у них …

Background: We aimed to compare efficacy of vonoprazan-dual or triple therapies and
bismuth-quadruple therapy for treatment-naive Helicobacter pylori (HP) infection in Southern …

Inleiding: Het aantal ziekenhuisopnames op intensieve zorg (IZ) van patiënten met als
comorbiditeit obesitas stijgt. Het instellen van een adequate dosering van anti-infectieuze …

Kubíčková V., Urbánek K.: Pharmacokinetics and therapeutic monitoring of piperacillin/
tazobactam Given their wide therapeutic index, β-lactam antibiotics are commonly used to …